Yuanrong Dai

机构：Central South University, Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Second Xiangya Hospital of Central South University

发表论文 21 篇 · 总被引 110 次 · h-index 4

代表论文

Expression of cytokines, growth factors and apoptosis-related signal molecules in chronic pressure ulcer wounds healing (2013 · Spinal Cord · 被引 70)
Efficacy and safety of mepolizumab in a Chinese population with severe asthma: a phase III, randomised, double-blind, placebo-controlled trial (2024 · ERJ Open Research · 被引 13)
Massive cryptogenic hemoptysis undergoing pulmonary resection: clinical and pathological characteristics and management. (2015 · PubMed · 被引 11)
Clinical Remission Outcome in Chinese Patients With Severe Asthma With an Eosinophilic Phenotype Receiving Mepolizumab: A Post-hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (2025 · Allergy Asthma and Immunology Research · 被引 4)
Clinical Remission Outcome in Patients with Severe Asthma with an Eosinophilic Phenotype (SA-EP) Receiving Mepolizumab: A Post-Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (2024 · Journal of Allergy and Clinical Immunology · 被引 3)
Selenium-vacancy-mediated NiCoSe nanoplatforms with NIR-II amplified nanozymes for methicillin-resistant Staphylococcus aureus -infected pneumonia (2025 · Biomaterials Science · 被引 2)